Opći podaci o projektu
Naziv projekta: Uloga bradikinina i glukoznih transportera u kognitivnim i neurovaskularnim promjenama uzrokovanima dijabetesom (CANDy)
Naziv projekta na engleskom jeziku: The role of bradykinin and glucose transporters in diabetes induced cognitive and neurovascular dysfunction (CANDy)
Voditelj projekta: izv. prof. dr. sc. Marina Radmilović
Ustrojbena jedinica: Zavod za histologiju i embriologiju, Medicinski fakultet Sveučilišta u Zagrebu (Department of Histology and Embryology, University of Zagreb School of Medicine)
Trajanje projekta: od 5. prosinca 2025. do 4. prosinca 2028. (36 mjeseci)
Ukupni iznos sredstava projekta: 199.996,50 €
Izvor financiranja: Hrvatska zaklada za znanost (Croatian Science Foundation - HRZZ)
Opis projekta
Dijabetes melitus povezan je s progresivnim metaboličkim, neurovaskularnim i funkcionalnim promjenama u središnjem živčanom sustavu koje pridonose povećanom riziku od kognitivnih poremećaja, neurodegenerativnih bolesti i cerebrovaskularnih komplikacija. Poremećaji moždanog metabolizma glukoze smatraju se jednim od važnih čimbenika u patofiziologiji ovih komplikacija. Transport glukoze kroz krvno-moždanu barijeru i njezin unos u stanice živčanog sustava regulirani su transporterima glukoze (GLUT), čija je ekspresija i aktivnost ključna za održavanje energetske homeostaze mozga. Unatoč njihovoj važnosti, molekularni mehanizmi regulacije transportera glukoze u fiziološkim i dijabetičkim uvjetima još uvijek nisu u potpunosti razjašnjeni. Bradikininski signalni sustav, osobito bradikininski receptor tipa 2 (B2R), ima važnu ulogu u regulaciji vaskularne funkcije, dok novija istraživanja upućuju i na njegovu uključenost u regulaciju transportera glukoze u perifernim tkivima. Međutim, uloga B2R-a u regulaciji moždanog metabolizma glukoze ostaje gotovo neistražena. Prethodna istraživanja našeg istraživačkog tima pokazala su da nedostatak B2R-a utječe na neuroregenerativni potencijal moždanog tkiva nakon ishemijskog oštećenja, dok preliminarni rezultati upućuju na promijenjenu ekspresiju transportera glukoze u mozgu miševa s nedostatkom B2R. Ovi nalazi predstavljaju polazište za istraživanje funkcionalne povezanosti bradikininskog signalnog sustava i regulacije transporta glukoze u mozgu. Projekt CANDy usmjeren je na razjašnjavanje uloge B2R u regulaciji ekspresije i aktivnosti transportera glukoze te njegovu povezanost s promjenama moždanog metabolizma u dijabetesu tipa 1. Istraživanjem će se utvrditi utječe li nedostatak B2R na unos glukoze u mozak u fiziološkim uvjetima i dijabetesu te identificirati unutarstanični signalni mehanizmi uključeni u regulaciju transportera glukoze. Kombinacijom magnetske rezonancije i fluorescencijskog oslikavanja, molekularnih i biokemijskih analiza, imunofluorescencijske mikroskopije te funkcionalnih i ponašajnih testova omogućit će se integrirana procjena metaboličkih, neurovaskularnih i kognitivnih promjena. Istraživanja na primarnim kulturama neurona, astrocita i endotelnih stanica omogućit će dodatnu karakterizaciju molekularnih mehanizama regulacije transportera glukoze putem B2R-a, uključujući signalne putove i promjene unutarstanične lokalizacije transportera. Očekuje se da će rezultati pridonijeti razumijevanju uloge bradikininskog signalnog sustava u održavanju moždane energetske homeostaze i patofiziologiji dijabetesom povezanih neurovaskularnih i kognitivnih poremećaja. Identifikacija signalnih mehanizama koji povezuju bradikininski receptor tip 2 i transportere glukoze mogla bi pružiti osnovu za buduća istraživanja novih terapijskih pristupa usmjerenih na metaboličke i neurovaskularne komplikacije dijabetesa.
EN Diabetes mellitus is associated with progressive metabolic, neurovascular, and functional alterations in the central nervous system that contribute to an increased risk of cognitive impairment, neurodegenerative diseases, and cerebrovascular complications. Disturbances in cerebral glucose metabolism are considered important factors in the pathophysiology of these complications. Glucose transport across the blood–brain barrier and its uptake into nervous system cells are mediated by glucose transporters (GLUTs), whose expression and activity are essential for maintaining cerebral energy homeostasis. Despite their importance, the molecular mechanisms regulating glucose transporters under physiological and diabetic conditions remain incompletely understood. The bradykinin signalling system, particularly the bradykinin B2 receptor (B2R), plays an important role in the regulation of vascular function, while recent studies also suggest its involvement in the regulation of glucose transporters in peripheral tissues. However, the role of B2R in regulating cerebral glucose metabolism remains largely unexplored. Previous studies conducted by our team demonstrated that B2R deficiency affects the neuroregenerative potential of brain tissue following ischaemic injury, while preliminary findings indicate altered glucose transporter expression in the brains of B2R-deficient mice. These findings provide the basis for investigating the functional relationship between the bradykinin signalling system and the regulation of glucose transport in the brain. Our project CANDy aims to elucidate the role of B2R in regulating glucose transporter expression and activity and its association with alterations in cerebral metabolism in type 1 diabetes. The study will determine whether B2R deficiency affects cerebral glucose uptake under physiological and diabetic conditions and identify the intracellular signalling mechanisms involved in glucose transporter regulation. By combining magnetic resonance imaging and fluorescence imaging, molecular and biochemical analyses, immunofluorescence microscopy, and functional and behavioural assessments, the project will enable an integrated evaluation of metabolic, neurovascular, and cognitive alterations. Studies using primary cultures of neurons, astrocytes, and endothelial cells will allow further characterisation of the molecular mechanisms underlying B2R-mediated regulation of glucose transporters, including intracellular signalling pathways and changes in transporter subcellular localisation. The findings are expected to advance our understanding of the role of the bradykinin signalling system in maintaining cerebral energy homeostasis and in the pathophysiology of diabetes-associated neurovascular and cognitive disorders. Identifying the signalling mechanisms linking the bradykinin B2 receptor to glucose transporters may provide a foundation for future investigations into novel therapeutic approaches targeting the metabolic and neurovascular complications of diabetes.
Ciljevi projekta
Opći cilj: Cilj je projekta istražiti ulogu bradikininskog receptora tipa 2 u regulaciji transportera glukoze i metabolizma glukoze u mozgu te njegovu povezanost s neurovaskularnim i kognitivnim promjenama u dijabetesu.
EN The project aims to investigate the role of the bradykinin type 2 receptor in the regulation of glucose transporters and cerebral glucose metabolism, and its association with neurovascular and cognitive alterations in diabetes.
Specifični ciljevi:
- Istražiti ulogu bradikininskog receptora tipa 2 u unosu glukoze u mozak posredovanom glukoznim transporterima u nedijabetičnih životinja.
- Istražiti temeljne mehanizme regulacije aktivnosti transportera glukoze posredovane bradikininskim receptorom tipa 2 u primarnim staničnim kulturama.
- Istražiti ulogu bradikininskog receptora tipa 2 u unosu glukoze u mozak posredovanom transporterima glukoze u dijabetičnih životinja.
- Procijeniti utjecaj dijabetesa i nedostatka bradikininskog receptora tipa 2 na neurovaskularne promjene i kognitivno propadanje.
EN
- To investigate the role of the bradykinin type 2 receptor in glucose transporter-mediated glucose uptake into the brain in non-diabetic animals.
- To investigate the underlying mechanisms of bradykinin type 2 receptor-mediated regulation of glucose transporter activity in primary cell cultures.
- To investigate the role of the bradykinin type 2 receptor in glucose transporter-mediated glucose uptake into the brain in diabetic animals.
- To assess the effects of diabetes and bradykinin type 2 receptor deficiency on neurovascular alterations and cognitive decline.
Metodologija projektnog istraživanja
Kako bi se istražila uloga bradikininskog receptora tipa 2 u regulaciji transportera glukoze i metabolizma glukoze u mozgu te njegov doprinos neurovaskularnim i kognitivnim promjenama povezanima s dijabetesom, projekt će objediniti istraživanja na eksperimentalnim životinjskim modelima i primarnim staničnim kulturama. Istraživanje će se provoditi na četiri skupine miševa: divlji tip, miševi s nedostatkom bradikininskog receptora tipa 2, miševi s dijabetesom tipa 1 te dijabetični miševi s nedostatkom bradikininskog receptora tipa 2. Usporedbom ovih skupina istražit će se uloga nedostatka bradikininskog receptora tipa 2 u fiziološkim uvjetima i dijabetesu. Metodologija obuhvaća primjenu suvremenih in vivo slikovnih metoda, uključujući pretkliničku magnetsku rezonanciju (7T Bruker BioSpec) i fluorescencijsko oslikavanje (IVIS Spectrum), kojima će se istraživati metabolizam glukoze, moždana perfuzija i mikrostrukturne promjene moždanog tkiva. Uz praćenje metaboličkog statusa životinja, standardiziranim testovima ponašanja procjenjivat će se njihove kognitivne i lokomotorne funkcije. Molekularnim, biokemijskim i mikroskopskim metodama istraživat će se ekspresija, raspodjela i funkcija transportera glukoze u različitim stanicama i regijama mozga. Istraživanja na primarnim kulturama neurona, astrocita i endotelnih stanica omogućit će detaljnije proučavanje mehanizama kojima bradikininski receptora tipa 2 utječe na transport glukoze, stanični metabolizam i unutarstanične signalne putove. U tu svrhu koristit će se metode RT-qPCR, Western blot, ELISA i konfokalna mikroskopija (Olympus FV3000), uz odgovarajuće farmakološke pristupe. Za obradu i analizu prikupljenih podataka koristit će se specijalizirani programski alati ParaVision, suMRak, Living Image, FIJI/ImageJ i GraphPad Prism. Integracijom rezultata dobivenih na razini organizma, tkiva i pojedinačnih stanica nastojat će se razjasniti uloga bradikininskog receptora tipa 2 u regulaciji moždanog metabolizma glukoze i njegov mogući doprinos razvoju neurovaskularnih i kognitivnih poremećaja povezanih s dijabetesom.
EN To investigate the role of the bradykinin type 2 receptor in the regulation of glucose transporters and cerebral glucose metabolism, as well as its contribution to diabetes-associated neurovascular and cognitive alterations, the project will combine studies using experimental animal models and primary cell cultures. The study will involve four groups of mice: wild-type mice, bradykinin type 2 receptor-deficient mice, mice with type 1 diabetes, and diabetic mice with bradykinin type 2 receptor deficiency. Comparisons between these groups will allow the effects of bradykinin type 2 receptor deficiency to be investigated under physiological and diabetic conditions. The methodology combines advanced in vivo imaging techniques, including preclinical magnetic resonance imaging (7T Bruker BioSpec) and fluorescence imaging (IVIS Spectrum), to investigate cerebral glucose metabolism, brain perfusion, and microstructural alterations in brain tissue. In addition to monitoring the metabolic status of the animals, cognitive and locomotor functions will be evaluated using standardised behavioural tests. Molecular, biochemical, and microscopic approaches will be used to investigate the expression, distribution, and function of glucose transporters in different brain regions and cell types. Studies using primary cultures of neurons, astrocytes, and endothelial cells will provide further insight into the mechanisms by which the bradykinin type 2 receptor influences glucose transport, cellular metabolism, and intracellular signalling pathways. These investigations will employ RT-qPCR, Western blotting, ELISA, and confocal microscopy (Olympus FV3000), together with appropriate pharmacological approaches. Data processing and analysis will be performed using specialised software tools, including ParaVision, suMRak, Living Image, FIJI/ImageJ, and GraphPad Prism. By integrating findings at the whole-organism, tissue, and cellular levels, the project aims to elucidate the role of the bradykinin type 2 receptor in regulating cerebral glucose metabolism and its potential contribution to the development of diabetes-associated neurovascular and cognitive disorders.
Očekivani rezultati
- Nove spoznaje o ulozi bradikininskog receptora tipa 2 u regulaciji moždanog metabolizma glukoze u fiziološkim uvjetima, s posebnim naglaskom na ekspresiju i funkciju glukoznih transportera.
- Bolje razumijevanje molekularnih mehanizama povezanosti bradikininskog receptora tipa 2 i transportera glukoze te njihove uloge u regulaciji metabolizma glukoze u neuronima, astrocitima i endotelnim stanicama mozga.
- Nove spoznaje o utjecaju dijabetesa na regulaciju transporta glukoze putem bradikininskog receptora tipa 2, uključujući moguće promjene u ekspresiji i aktivnosti transportera glukoze te njihov doprinos poremećajima moždane energetske homeostaze.
- Bolje razumijevanje povezanosti dijabetesa, bradikininskog receptora tipa 2 i neurovaskularnih i kognitivnih poremećaja, osobito u kontekstu promjena moždane perfuzije, mikrostrukture tkiva i metabolizma glukoze.
EN
- New insights into the role of the bradykinin type 2 receptor in the regulation of cerebral glucose metabolism under physiological conditions, with particular emphasis on glucose transporter expression and function.
- Improved understanding of the molecular mechanisms linking the bradykinin type 2 receptor and glucose transporters, and their role in regulating glucose metabolism in neurons, astrocytes, and brain endothelial cells.
- New insights into the effects of diabetes on bradykinin type 2 receptor-mediated regulation of glucose transport, including potential alterations in glucose transporter expression and activity and their contribution to disturbances in cerebral energy homeostasis.
- Improved understanding of the relationship between diabetes, the bradykinin type 2 receptor, and neurovascular and cognitive disorders, particularly in the context of alterations in cerebral perfusion, tissue microstructure, and glucose metabolism.
Projektni tim
Popis osoba projektnog tima s Medicinskog fakulteta Sveučilišta u Zagrebu:
- Izv. prof. dr. sc. Marina Radmilović
- Dr. sc. Anja Barić
- Dr. sc. Helena Justić
- Dr. sc. Milorad Zjalić
- Marta Pongrac, mag. biotechn. in med.
- Doc. dr. sc. Siniša Škokić
- Ivana Šantek, mag. biol. exp.
- Sandra Grgić, ing. med. lab. dg.
Popis osoba projektnog tima partnera: Vanjski suradnici (Project collaborators):
- Prof. dr. sc. Philipp Boehm-Sturm, Ph.D., Department of Experimental Neurology, Center for Stroke Research, Charité – Universitätsmedizin Berlin, Germany; Dirk Wiedermann, Ph.D., Senior researcher, Multimodal Imaging Group, Max Planck Institute for Metabolism Research, Cologne, Germany
Diseminacija i vidljivost projekta
Diseminacija rezultata i povećanje vidljivosti projekta CANDy provodit će se kroz sudjelovanje na nacionalnim i međunarodnim znanstvenim skupovima, objavljivanje rezultata u međunarodnim znanstvenim časopisima te suradnju s domaćim i inozemnim istraživačkim institucijama. Poseban doprinos diseminaciji i međunarodnoj vidljivosti projekta očekuje se kroz Small Animal MRI Symposium (SAMS 2027), koji će se održati 3. i 4. lipnja 2027. godine na Medicinskom fakultetu Sveučilišta u Zagrebu. Simpozij će okupiti međunarodne stručnjake iz područja pretkliničkog oslikavanja magnetskom rezonancijom te omogućiti razmjenu znanstvenih spoznaja, predstavljanje istraživačkih metoda i rezultata te poticanje novih znanstvenih suradnji. Poseban naglasak bit će na razmjeni znanja i stručnom usavršavanju mladih istraživača.
EN Dissemination of research findings and enhancement of the CANDy project's visibility will be achieved through participation in national and international scientific meetings, publication of results in international scientific journals, and collaboration with national and international research institutions. A significant contribution to the dissemination and international visibility of the project is expected through the Small Animal MRI Symposium (SAMS 2027), which will take place on 3–4 June 2027 at the University of Zagreb School of Medicine. The symposium will bring together international experts in preclinical magnetic resonance imaging, providing opportunities for scientific exchange, presentation of research methods and findings, and the establishment of new research collaborations. Particular emphasis will be placed on knowledge exchange and the professional development of early-career researchers.